索宝蛋白(603231) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 392,657,748.16, representing a decrease of 4.55% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 37,265,469.75, an increase of 47.77% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 33,185,571.63, up by 32.04% compared to the previous year[4] - Basic and diluted earnings per share were both CNY 0.19, reflecting a growth of 5.56%[4] - Total operating revenue for Q1 2024 was ¥392,657,748.16, a decrease of 4.3% compared to ¥411,395,508.19 in Q1 2023[16] - Net profit for Q1 2024 reached ¥37,265,469.75, an increase of 47.7% compared to ¥25,218,829.04 in Q1 2023[17] - Earnings per share for Q1 2024 were ¥0.19, up from ¥0.18 in Q1 2023[18] Cash Flow and Liquidity - The net cash flow from operating activities reached CNY 18,553,120.73, a significant increase of 374.75% year-on-year[4] - Cash inflow from operating activities was ¥466,986,543.15 in Q1 2024, slightly up from ¥466,046,743.70 in Q1 2023[19] - The net cash flow from operating activities for Q1 2024 was $18,553,120.73, a significant increase from $3,907,958.79 in Q1 2023, reflecting improved operational efficiency[20] - The total cash and cash equivalents at the end of Q1 2024 amounted to $350,784,464.51, down from $1,073,142,131.62 at the beginning of the quarter, indicating a significant decrease in liquidity[21] - The total operating cash outflow was $448,433,422.42, slightly lower than $462,138,784.91 in Q1 2023, indicating stable operational costs[20] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,129,297,349.55, a decrease of 0.52% from the end of the previous year[4] - The company's current assets totaled ¥1,468,641,866.02, down from ¥1,488,723,140.98, indicating a decrease of about 1.73%[13] - Total liabilities decreased to ¥202,687,604.40 in Q1 2024 from ¥251,122,161.42 in Q1 2023, a reduction of 19.2%[16] - The total liabilities decreased from ¥1,488,723,140.98 to ¥1,468,641,866.02, a decline of about 1.35%[13] - The company reported a total of ¥567,954,580.64 in fixed assets, down from ¥574,737,962.16, indicating a decrease of about 1.2%[13] Operational Efficiency - The increase in net profit was primarily attributed to the appreciation of the US dollar, increased interest income, recovery of previously provided bad debts, and a decrease in the cost of major raw materials[7] - Research and development expenses decreased to ¥1,329,836.11 in Q1 2024 from ¥2,895,576.83 in Q1 2023, a decline of 54.0%[16] - Financial expenses showed a significant improvement, with a net income of ¥5,041,406.07 in Q1 2024 compared to a loss of ¥3,768,596.69 in Q1 2023[16] Other Financial Activities - The company reported a non-recurring loss from the disposal of non-current assets amounting to CNY 1,780,922.67[6] - The company recognized government subsidies of CNY 2,422,239.21 that are closely related to its normal business operations[6] - The company paid $10,066,146.69 in taxes during the quarter, which is a significant increase from $5,642,780.22 in the same period last year, reflecting higher taxable income[20] - The cash paid to employees was $31,313,991.78, a decrease from $32,543,360.76 in Q1 2023, suggesting potential cost-cutting measures in personnel expenses[20] - The company experienced a foreign exchange impact of $2,378,100.48 on cash and cash equivalents, contrasting with a negative impact of -$2,402,188.83 in the previous year[21]